Skip to main content
SpringerLink
Log in
Book cover

Therapiekonzepte Onkologie pp 124–154Cite as

Akute lymphatische Leukämien

  • Chapter

  • 57 Accesses

Zusammenfassung

Während bei Kindern die akute lymphatische Leukämie (ALL) zu den häufigsten bösartigen Erkrankungen zählt, tritt sie im Erwachsenenalter eher selten auf. Die Inzidenz liegt bei 1/100000, wobei in der Altersgruppe > 55 Jahren ein leichter Anstieg zu beobachten ist. Die Erkrankungshäufigkeit insbesondere für bestimmte Untergruppen der ALL ist bei Männern höher als bei Frauen (1,4:1,0) [48].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Arlin Z, Feldman E, Mittelman A, Ahmed T, Cook P, Puccio C, Chun HG, Baskind P (1991) High dose short course mitoxantrone (M) with high dose cytarabine (HiDac) is safe effective therapy for acute lymphoblastic leukemia (ALL). Proc ASCO 10: 223

    Google Scholar 

  2. Barrett AJ, Horowitz MM, Bortin MM (1991) For the IBMTR. HLA-identical sibling bone marrow transplants for Ph’-chromosome positive acute lymphoblastic leukemia in first remission. Exp Haematol 19: 569

    Google Scholar 

  3. Bassan R (1992) Reinforced HEAV’D Therapy for Adult Lymphoblastic Leukemia: Improved Results and Revised Prognostic Criteria. Hematol Oncol 11: 169

    Article  Google Scholar 

  4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the Classification of the Acute Leukaemias. Br J Haematol 33: 451

    Article  PubMed  CAS  Google Scholar 

  5. Berman E, Weiss M, Kempin S, Gee T, Bertino J, Clarkson B (1991) Intensive therapy for adult acute lymphoblastic leukemia. Semin Hematol 28: 72–75

    PubMed  CAS  Google Scholar 

  6. Biondi A, Yokata S, Hansen-Hagge TE, Rosso V, Giudici G, Maglia O, Basso G, Tell C, Masera G, Bartram CR (1992) Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Analysis of Patients in Continuous Complete Remission or with Consecutive Relapse. Leukemia 6 (4): 282–288

    PubMed  CAS  Google Scholar 

  7. Bleyer WA (1990) Central nervous system leukemia. In: Henderson ES, Lister TA, eds. Philadelphia: W.B. Saunders Company, 733–768

    Google Scholar 

  8. Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgstroem GH, Brandt L, Catovsky D, de la Chapella A, Dewald GW et al. (1986) Chromosomal Abnormalities Identify High-Risk and Low-Risk Patients with Acute Lymphoblastic Leukemia. Blood 67 (2): 415–420

    PubMed  CAS  Google Scholar 

  9. Brennan C, Weisdorf D, Kersey J, Haake R, Ramsay N (1991) Bone marrow transplantation (BMT) for Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph’+ALL ). Proc ASCO 10: 222

    Google Scholar 

  10. Carella AM, Pollicardo N, Carlier P, Raffo MR, Podesta M, Dantini G, Congui A, Valbonesi M, Lercari G, Vitale V, Corvo P, Gallamini A, Parodi M (1992) „Normal“peripheral blood stem cells (PBSC) mobilization by myelosuppressive chemotherapy in very high-risk acute lymphoblastic leukemia (ALL) with cytogenetic translocations. Leuk Lymphoma 7: 19–21

    Google Scholar 

  11. Cassileth PA, Andersen JW, Hoagland HC, Mazza JJ, Bennett JM, Hahn RG, Tormey DC, O’Connell MJ. (1990) High-dose cytarabine therapy in adult acute lymphocytic leukemia. In: Gale RP, Hoelzer D, eds. Acute Lymphoblastic Leukemia. New York: Alan R Liss, 197–203

    Google Scholar 

  12. Clarkson B, Gaynor J, Little C, Berman E, Kempin S, Andreeff M, Gulati S, Cunningham I, Gee T (1990) Importance of Long-Term Follow-up in Evaluating Treatment Regimens for Adults with Acute Lymphoblastic Leukemia. Haematol Blood Trans 33: 397

    CAS  Google Scholar 

  13. Cuttner J, Mick R, Budman DR et al. (1991) Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: A CALGB study. Leukemia 5: 425–431

    PubMed  CAS  Google Scholar 

  14. Durrant IJ (1993) Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia. Br J Haematol 85: 84–92

    Article  PubMed  CAS  Google Scholar 

  15. Elonen E, Almqvist A, Hänninen A, Jansson S-E, Järventie G, Koistinen P, Koivunen E, Lahtinen M (1991) Intensive tratment of acute lymphatic leukaemia in adults: ALL86 protocol. Haematologica 76 (Suppl 4): 133

    Google Scholar 

  16. Fenaux P, Lai JL, Miaux O, Zandecki M, Jouet JP, Bauters F (1989) Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases. Br J Haematol 71: 371–376

    Article  PubMed  CAS  Google Scholar 

  17. Fiere D (1993) Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marroy transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastik Leukemia. J Clin Oncol 11: 1990–2001

    PubMed  CAS  Google Scholar 

  18. Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP, Varet B et al. (1993) Adult Acute Lymphoblastic Leukemia: A Multicentric Randomized Trial Testing Bone Marrow Transplantation as Postremission Therapy. J Clin Oncol 11 (10): 1990–2001

    PubMed  CAS  Google Scholar 

  19. Freund M, Diedrich H, Ganser A, Gramatzki M, Heil G, Heyll A, Henke M, Hiddemann W et al. (1992) Treatment of Relapsed or Refractory Adult Acute Lymphocytic Leukemia. Cancer 69: 709–716

    Article  PubMed  CAS  Google Scholar 

  20. Freund M, Heil G, Arnold R, Bartram C, Büchner Th, Diedrich H, Fonatsch C, Ganser A, Hiddemann W, Koch P, Link H, Löffler H, Ludwig WD, Machmeyer G, Schmitz N, Thiel E, Hoelzer D (1994) Treatment of relapsed or refractory adult acute lymphocytic leukemia. Ann Hematol 68, Suppl I: A10

    Google Scholar 

  21. Gaynor J, Chapman D, Little C, McKenzie S, Miller W, Andreff M, Arlin ZA, Berman E, Kempin S, Gee T, Clarkson B (1969) A Cause-Specific Hazard Rate Analysis of Prognostic Factors Among 199 Adults With Acute Lymphoblastic Leukemia: The Memorial Hospital Experience Since. J Clin Oncol 6 (6): 1014–1030

    Google Scholar 

  22. Haas OA, Mor W, Gadner H, Bartram CR (1988) Treatment of Ph-positive acute lymphoblastic leukemia with A-interferon. Leukemia 2: 555

    PubMed  CAS  Google Scholar 

  23. Henslee-Downey Pi, Fleming D, Kryscio R, Romond E, Harder E (1991) Does mismatched bone marrow transplant (MMBMT) from related or unrelated donors offer successful salvage therapy for patients (pts) with relapsed acute lymphoblastic leukemia. Haematologica 76 (Suppl 4): 69

    Google Scholar 

  24. Hoelzer D (1991) High-Dose Chemotherapy in Adult Acute Lymphoblastic Leukemia. Sem Hematol 28(3) Suppl 4: 84–89

    Google Scholar 

  25. Hoelzer D (1991) Diagnosis and treatment of adult acute lymphocytic leukemia. In: Wiernik PH, Canellos GP, Keyle RA, Schieffer CA, eds. Neoplastic diseases of the Blood. New York: Churchill Livingstone, 253–274

    Google Scholar 

  26. Hoelzer D (1993) Aggressive Chemotherapy of ALL in Elderly Patients. Hematol Oncol 11 Suppl 1: 12–14

    Google Scholar 

  27. Hoelzer D (1993) Acute lymphoblastic leukemia — progress in children, less in adults. New Engl J Med 329: 1343–1344

    Article  PubMed  CAS  Google Scholar 

  28. Hoelzer D (1994) Treatment of acute lymphoblastic leukemia. Semin Hematol 31: 1–15

    PubMed  CAS  Google Scholar 

  29. Hoelzer D (1994) Therapy and prognostic factors in adult acute lymphoblastic leukemia. Bailliere’s Clinical Haematology 7 (2): 299

    Article  CAS  Google Scholar 

  30. Hoelzer D, Thiel E, Löffler H, Büchner T, Freund M, Ganser A, Heil G, Hiddemann W et al. (1990) Intensified Chemotherapy and Mediastinal Irradiation in Adult T-Cell Acute Lymphoblastic Leukemia. In: Acute Lymphoblastic Leukemia. Alan R. Liss, Inc, 221–229

    Google Scholar 

  31. Hoelzer D, Thiel E, Ludwig WD, Büchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Völkers B, Gökbuget N, Aydemir i.7 (1993) Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). Leukemia Suppl 2: 130–134

    Google Scholar 

  32. Hoelzer D, Thiel E, Ludwig WD, Büchner T, Freund M, Heil G (1992) The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia (in press)

    Google Scholar 

  33. Hoelzer D, Thiel E, Ludwig WD, Büchner T, Freund M, Heil G, Hiddemann W et al. (1992) The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia 6 Suppl 2: 175–177

    Google Scholar 

  34. Hoelzer D, Thiel E, Ludwig WD, Büchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Völkers B, Gökbuget N, Aydemir GAASG (1993) Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). Leukemia 7 (Suppl 2): S 130—S 134

    Google Scholar 

  35. Hooberman A, Westbrook C, Spino C, Wurster-Hill D, Sobol R, Davey F, Larson R (1991) Clinical significance of molecular detection of the BCR-ABL fusion gene in acute lymphoblastic leukemia (ALL): a Cancer and Leukemia Group B ( CALGB) study. Proc ASCO 10: 222

    Google Scholar 

  36. Horowitz MM; Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett J, Büchner T, Freund M, Heil G, Hiddemann W, Kolb H-J, Löffler H, Marmont AM, Maschmeyer G, Rimm AA, Rozman C, Sobocinski KA, Speck B, Thiel E, Weisdorf DJ, Zwaan FE, Bortin MM (1991) Chemotherapy compared with bone marrow transplantation for adult with acute lymphoblastic leukemia in first remisson. Ann Hematol 115: 13–18

    CAS  Google Scholar 

  37. Kantarjian H, Estey E, O’Brien S, Robertson LB, Beran M, Pierce S, Keating M (1992) Granulocyte-colony stimulating factor (G-CSF) supportive care following intensive chemotherapy consolidation in acute lymphocytic leukemia (ALL) in first remission. Blood 80 (Suppl 1): 112 a

    Google Scholar 

  38. Kantarjian HM, Walters RS, Keating MJ, Smith TL, O’Brien S, Estey EH, Huh YO, Spinolo J et al. (1990) Results of the Vincristine, Doxorubicin, and Dexamethasone Regimen in Adults With Standard-and High-Risk Acute Lymphocytic Leukemia. J Clin Oncol 8: 994–1004

    PubMed  CAS  Google Scholar 

  39. Kantarjian HM, Walters RS, Smith TL, Keating MJ, Barlogie B, McCredie KB, Freireich EJ (1988) Identificaton of Risk Groups for Development of Central Nervous System Leukemia in Adults with Acute Lymphocytic Leukemia. Blood 72 (5): 1784–1789

    PubMed  CAS  Google Scholar 

  40. Linker CA, Levitt LJ, O’Donnell M, Forman SJ, Ries CA (1991) Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood 78: 2814–2822

    PubMed  CAS  Google Scholar 

  41. Lluesma-Gonalons M, Pavlovsky S, Santarelli MT, Eppinger-Helf M, Bavea ED, Corrado C, Carnot J et al. (1991) Improved results of an intensified therapy in adult acute lymphocytic leukemia. Annals of Oncology 2: 33–39

    PubMed  CAS  Google Scholar 

  42. Ludwig WD, Harbott J, Rieder H, Bartram CR, Maurer J, Becher R, Heinze B, Gassmann W, Drexler HG, Martin M, Sperling C, Völkers B, Reiter A, Ritter J, Hiddemann W, Büchner T, Löffler H, Fonatsch C, Hoelzer D, Riehm H, Thiel E (1994) Incidence, Biologic Features and Treatment Outcome of Myeloid-AntigenPositive. Acute Lymphoblastic Leukemia (My+ALL. In: Büchner et al., ed. Acute Leukemias I V. Prognostic Factors. Springer-Verlag, Berl in Heidelberg

    Google Scholar 

  43. Ludwig WD, Maurer J, Bartram CR et al. (1991) Bedeutung zellbiologischer Merkmale von Leukämiezellen für die Entwicklung risikoadaptierter Therapiestrategien bei akuten lymphatischen Leukämien (ALL). Wissenschaftswoche 1991 Universität Steglitz der Freien Universität Berlin 58–60

    Google Scholar 

  44. Ludwig WD, Raghavachar A, Thiel E (1994) Immunophenotypic classification of acute lymphoblastic leukemia. Bailliere’s Clinical Haematology 7 (2): 235

    Article  CAS  Google Scholar 

  45. Marie J-P, Zittoun R, Sikic BI (1991) Multidrug resistance (mdr-1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78: 586–592

    PubMed  CAS  Google Scholar 

  46. Martin H, Atta J, Bruecher J, Claudé R, Elsner S, Hoelzer D (1993) Minimal residual disease in patients with Ph-positive acute lymphoblastic leukemia before and after autologous bone marrow transplantation. Exp Hematol 21: 1065

    Google Scholar 

  47. Maurer J, Janssen JWG, Thiel E, van Denderen J, Ludwig WD, Aydemir C, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR (1991) Detection of chimeric BCR-ABL genes in acute lymphoblastic leukemia by the polymerase chain reacton. Lancet 337: 1055

    Article  PubMed  CAS  Google Scholar 

  48. McKinney Pa, Alexander FE, Cartwright RA, Ricketts TJ (1989) The Leukemia Research Fund Data Collection Study: Descriptive Epidemiology of Acute Lymphoblastic Leukemia. Leukemia 3 (12): 880–885

    Google Scholar 

  49. Meloni G, Foa R, Tosti S, Vignett M, Mancini F, Guarini A, Marchis D, Gavosto F, Mandelli F (1992) Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study. Leukemia 6: 780–785

    PubMed  CAS  Google Scholar 

  50. Ohyashiki K, Ohyashiki JH, Tauchi T, Fujieda H, Hojo H, Ohtaka M, Daito M, Nakazawa S, Toyama K (1991) Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a pilot study which raises important questions. Leukemia 5: 611–614

    PubMed  CAS  Google Scholar 

  51. Ottman OG, Hoelzer D, Gracien E, Kelly K, Ganser A, Reutzel R, Lipp T, Busch FW, Schwonzen M, Wandt H, Heil G, Koch P, Heyll A, Meyer P, Pentz M, Peter S, Diedrich H, Kolbe K (1993) Concomitant R-metHuG-CSF (Filgrastim) and intensive chemoradiotherapy as induction treatment in adult ALL: a randomized multicenter Phase III trial. Blood 82 (Suppl 1): 193 a

    Google Scholar 

  52. Patte C, Leverger G, Rubie H, Bertrand Y, Coze C, Méchinaud F, Lutz P, Michon J, Baruchel A, Courbon BS (1993) High cure rate in B-cell (Burkitt’s leukemia in the LMB 89 protocol of the SFOP (French Pediatric Oncology Society). Proc ASCO 12: 317

    Google Scholar 

  53. Potter MN, Cross NCP, van Dongen JJM, Saglio G, Oakhill A, Bartram CR, Goldman LM (1993) Molecular evidence of minimal residual disease after treatment for leukemia and lymphoma: an updated meeting report and review. Leukemia 7: 1302–1314

    PubMed  CAS  Google Scholar 

  54. Reiter A (1994) Therapy of B-cell acute lymphoblastic leukaemia in childhood: The BFM experience. Bailliere’s Clinical Haematology 7 (2): 321

    Article  CAS  Google Scholar 

  55. Rieder H, Ludwig WD, Gassmann W, Thiel E, Löffler H, Hoelzer D, Fonatsch C (1993) Chromosomal Abnormalities in Adult Acute Lymphoblastic Leukemia: Results of the German ALL/AUL Study Group. Recent Res Cancer Res 131: 133

    Article  CAS  Google Scholar 

  56. Rohatiner AZS, Bassan R, Battista R, Barnett MJ, Gregory W, Lim J, Amess J, Oza B, Barbui T (1990) High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukemia. Br J Cancer 62: 454–458

    Article  PubMed  CAS  Google Scholar 

  57. Schiffer CA, Larson RA, Bloomfieed CD (1992) Cancer and leukemia group B (CALGB) studies in adult acute lymphocytic leukemia. Leukemia 6 (suppl 2): 171–174

    PubMed  Google Scholar 

  58. Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV (1991) Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia 5: 196–199

    PubMed  CAS  Google Scholar 

  59. Stryckmans P, de Witte T, Marie JP, Fillet G, Peetermans M, Bury J, Muus P, Andrien JM, Hayat M, Jaksic B, Labar B, Debusscher L, Solbu G, Suciu S, Zittoun R (1992) Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). Leukemia 6 (Suppl 2): 199–203

    PubMed  Google Scholar 

  60. Stryckmans P, Debusscher L (1991) Chemotherapy of adult acute lymphoblastic leukaemia. Baillère’s Clinical Haematology 4: 115–130

    Article  CAS  Google Scholar 

  61. Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD (1992) Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study (8762). Blood 80: 2983–2990

    PubMed  CAS  Google Scholar 

  62. Wiernik PH, Dutcher JP, Paietta E, Gucalp R, Markus S, Weinberg V, Azar C, Garl S, Benson L (1993) Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Leukemia 7: 1236–1241

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. Hoelzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Gökbuget
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung) Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hoelzer, D., Gökbuget, N. (1995). Akute lymphatische Leukämien. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10494-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10494-1_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58586-2

  • Online ISBN: 978-3-662-10494-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation